David M. Thomson

5.4k total citations · 1 hit paper
136 papers, 4.1k citations indexed

About

David M. Thomson is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, David M. Thomson has authored 136 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Molecular Biology, 49 papers in Immunology and 37 papers in Physiology. Recurrent topics in David M. Thomson's work include Metabolism, Diabetes, and Cancer (32 papers), Immunotherapy and Immune Responses (32 papers) and Adipose Tissue and Metabolism (29 papers). David M. Thomson is often cited by papers focused on Metabolism, Diabetes, and Cancer (32 papers), Immunotherapy and Immune Responses (32 papers) and Adipose Tissue and Metabolism (29 papers). David M. Thomson collaborates with scholars based in United States, Canada and United Kingdom. David M. Thomson's co-authors include W. W. Winder, Phil Gold, Samuel O. Freedman, John Krupey, Scott E. Gordon, Nina Grosser, Jacques Marti, Natasha Fillmore, John K. MacFarlane and Peter Alexander and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

David M. Thomson

128 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

THE RADIOIMMUNOASSAY OF CIRCULATING CARCINOEMBRYONIC ANTIGEN OF THE HUMAN DIGESTIVE SYSTEM

1969 546 citations David M. Thomson et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by David M. Thomson

Since Specialization

Citations

This map shows the geographic impact of David M. Thomson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Thomson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Thomson more than expected).

Fields of papers citing papers by David M. Thomson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Thomson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Thomson. The network helps show where David M. Thomson may publish in the future.

Co-authorship network of co-authors of David M. Thomson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Thomson. A scholar is included among the top collaborators of David M. Thomson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Thomson. David M. Thomson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chronic treatment of old mice with AICAR reverses age‐related changes in exercise performance and skeletal muscle gene expression 2025 ·FASEB BioAdvances ·(unknown), (unknown), (unknown), Deborah K. Rasch, Andrew H. Smith, (unknown), Jonathon T. Hill, David M. Thomson	0
2	Small-molecule AMPK activation preserves anabolic signaling in a C2C12 myotube cachexia model 2024 ·Physiology ·(unknown), (unknown), (unknown), (unknown), (unknown), David M. Thomson	0
3	16p11.2 deletion mice exhibit compromised fronto-temporal connectivity, GABAergic dysfunction, and enhanced attentional ability 2023 ·Communications Biology ·(unknown), David M. Thomson, Greg C. Bristow, (unknown), Judith A. Pratt, Brian Morris, Neil Dawson	4
4	Glycan degradation promotes macroautophagy 2022 ·Proceedings of the National Academy of Sciences ·Alice D. Baudot, Victoria M.-Y. Wang, (unknown), Jim O’Prey, Jaclyn S. Long, Viola Paulus-Hock, Sérgio Lilla, David M. Thomson, (unknown), (unknown), Colin Nixon, Miep Helfrich, Douglas Strathdee, Judith A. Pratt, Francesco Marchesi, Sara Zanivan, Kevin M. Ryan	7
5	Lack of skeletal muscle liver kinase B1 alters gene expression, mitochondrial content, inflammation and oxidative stress without affecting high-fat diet-induced obesity or insulin resistance 2020 ·Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Ting Chen, Jonathon T. Hill, Timothy M. Moore, Eric C.K. Cheung, (unknown), (unknown), (unknown), Jeffery S. Tessem, (unknown), Benjamin T. Bikman, Jason M. Hansen, David M. Thomson	6
6	16p11 Duplication Disrupts Hippocampal-Orbitofrontal-Amygdala Connectivity, Revealing a Neural Circuit Endophenotype for Schizophrenia 2020 ·Cell Reports ·Greg C. Bristow, David M. Thomson, (unknown), (unknown), Judith A. Pratt, Neil Dawson, Brian Morris	22
7	Mice haploinsufficient for Map2k7, a gene involved in neurodevelopment and risk for schizophrenia, show impaired attention, a vigilance decrement deficit and unstable cognitive processing in an attentional task: impact of minocycline 2016 ·Psychopharmacology ·(unknown), David M. Thomson, Josef Penninger, Judith A. Pratt, Brian Morris	15
8	BRCA1 is a novel regulator of metabolic function in skeletal muscle 2014 ·Journal of Lipid Research ·Kathryn C. Jackson, (unknown), Jessica Norrbom, Alfonso Valencia, David M. Thomson, Rosemary A. Schuh, P. Darrell Neufer, Espen E. Spangenburg	27
9	Phosphorylation of VASP by AMPK alters actin binding and occurs at a novel site 2011 ·Biochemical and Biophysical Research Communications ·David M. Thomson, (unknown), (unknown), Cody S. Nelson, Marc D.H. Hansen	26
10	AMP‐activated protein kinase response to contractions and treatment with the AMPK activator AICAR in young adult and old skeletal muscle 2009 ·The Journal of Physiology ·David M. Thomson, Jacob D. Brown, Natasha Fillmore, (unknown), Daniel L. Jacobs, W. W. Winder, (unknown), Scott E. Gordon	31
11	Thyroid hormone effects on LKB1, MO25, phospho-AMPK, phospho-CREB, and PGC-1α in rat muscle 2008 ·Journal of Applied Physiology ·(unknown), (unknown), (unknown), Hyung Jun Kim, Natasha Fillmore, (unknown), Jonathan D. Brown, Sterling N. Sudweeks, David M. Thomson, W. W. Winder	42
12	Does AMP-Activated Protein Kinase Negatively Mediate Aged Fast-Twitch Skeletal Muscle Mass? 2008 ·Exercise and Sport Sciences Reviews ·Scott E. Gordon, (unknown), (unknown), David M. Thomson	31
13	AMPK activation attenuates S6K1, 4E-BP1, and eEF2 signaling responses to high-frequency electrically stimulated skeletal muscle contractions 2008 ·Journal of Applied Physiology ·David M. Thomson, (unknown), Scott E. Gordon	119
14	Cellular energy sensing and signaling by AMP-activated protein kinase 2007 ·Cell Biochemistry and Biophysics ·W. W. Winder, David M. Thomson	117
15	LKB1 and the regulation of malonyl-CoA and fatty acid oxidation in muscle 2007 ·American Journal of Physiology-Endocrinology and Metabolism ·David M. Thomson, Jacob D. Brown, Natasha Fillmore, (unknown), HJ Kim, Jeffery R. Barrow, W. W. Winder	52
16	AMP-activated protein kinase phosphorylates transcription factors of the CREB family 2007 ·Journal of Applied Physiology ·David M. Thomson, Seth T. Herway, Natasha Fillmore, Hoon Kim, Jonathan D. Brown, Jane Barrow, W. W. Winder	163
17	Skeletal muscle and heart LKB1 deficiency causes decreased voluntary running and reduced muscle mitochondrial marker enzyme expression in mice 2006 ·American Journal of Physiology-Endocrinology and Metabolism ·David M. Thomson, B. B. Porter, (unknown), Hyung Jun Kim, Jane Barrow, W. W. Winder	111
18	Impaired overload‐induced muscle growth is associated with diminished translational signalling in aged rat fast‐twitch skeletal muscle 2006 ·The Journal of Physiology ·David M. Thomson, Scott E. Gordon	75
19	Circulating Form of Beta-2-Microglobulin in Dialysis Patients 1988 ·American Journal of Nephrology ·Raymonde F. Gagnon, Peter J. Somerville, David M. Thomson	4
20	Requirement for autologous cancer extracts and lipoxygenation of arachidonic acid for human T-cell responses in leukocyte adherence inhibition and transmembrane potential change assays. 1984 ·PubMed ·George Shenouda, David M. Thomson, John K. MacFarlane	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact